BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26673424)

  • 1. DNA-based influenza vaccines as immunoprophylactic agents toward universality.
    Zhang H; El Zowalaty ME
    Future Microbiol; 2016; 11(1):153-64. PubMed ID: 26673424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
    Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L
    Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
    Grødeland G; Bogen B
    Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for developing an effective particle-mediated DNA vaccine against influenza.
    Yager EJ; Dean HJ; Fuller DH
    Expert Rev Vaccines; 2009 Sep; 8(9):1205-20. PubMed ID: 19722894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Plasmid DNA Vaccines: Progress and Prospects.
    Bicho D; Queiroz JA; Tomaz CT
    Curr Gene Ther; 2015; 15(6):541-9. PubMed ID: 26415574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Avian influenza vaccines].
    Vasil'ev IuM
    Vopr Virusol; 2008; 53(6):4-15. PubMed ID: 19172900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
    Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-based approaches to a universal influenza vaccine.
    Gottlieb T; Ben-Yedidia T
    J Autoimmun; 2014 Nov; 54():15-20. PubMed ID: 25172355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress and prospect of universal influenza vaccine].
    Luo DY; Xue CY; Cao YC
    Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prospects and challenges of universal vaccines for influenza.
    Subbarao K; Matsuoka Y
    Trends Microbiol; 2013 Jul; 21(7):350-8. PubMed ID: 23685068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
    Krammer F
    Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine: Where are we and where do we go?
    Keshavarz M; Mirzaei H; Salemi M; Momeni F; Mousavi MJ; Sadeghalvad M; Arjeini Y; Solaymani-Mohammadi F; Sadri Nahand J; Namdari H; Mokhtari-Azad T; Rezaei F
    Rev Med Virol; 2019 Jan; 29(1):e2014. PubMed ID: 30408280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against influenza: role and limitations in pandemic intervention plans.
    Rebmann T; Zelicoff A
    Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
    Wheatley AK; Kent SJ
    Expert Rev Vaccines; 2015; 14(9):1227-39. PubMed ID: 26175180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
    Fang F; Cai XQ; Chang HY; Wang HD; Yang ZD; Chen Z
    Acta Virol; 2008; 52(2):107-12. PubMed ID: 18564897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trends and perspectives in development of influenza vaccines].
    Sato K; Itamura S
    Nihon Rinsho; 2010 Sep; 68(9):1697-701. PubMed ID: 20845750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.